Health
Employers Don't Want to Pay for Life-Saving Cures for Rare Diseases
Some employers resist covering costly gene therapies, forcing workers to find other ways to get the treatments.
This article is for subscribers only.
As a wave of gene therapies with multimillion-dollar price tags hit the market, many employers are dropping coverage and leaving families in a bind.
For Amanda Reed, the blows came one after another, a gut-punch introduction to motherhood.